Salivary caffeine in Parkinson’s disease

Abstract We aimed to investigate salivary caffeine content, caffeine absorption and metabolism in Parkinson’s disease (PD) and verify whether salivary caffeine can be used as a biomarker of PD. We enrolled 98 PD patients and 92 healthy subjects. Caffeine and its major metabolite, paraxanthine, were...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giorgio Leodori, Maria Ilenia De Bartolo, Daniele Belvisi, Alessia Ciogli, Andrea Fabbrini, Matteo Costanzo, Simone Manetto, Antonella Conte, Claudio Villani, Giovanni Fabbrini, Alfredo Berardelli
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a18969ffd7364c09aa30c41879aa4f47
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares